Biology of factor IX.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Blood Coagulation and Fibrinolysis

• Publication date

  1992-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0889-8588(18)30288-0PMID 8148489
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regional localization of the human factor IX gene by molecular hybridization

  2004cited by this paper
• A new MspI restriction fragment length polymorphism in the hemophilia B locus

  2004cited by this paper
• The Ca2+ ion and membrane binding structure of the Gla domain of Ca-prothrombin fragment 1.

  1994cited by this paper
• Towards gene therapy for haemophilia B using primary human keratinocytes

  1993cited by this paper
• Synergy between transcription factors DBP and C/EBP compensates for a haemophilia B Leyden factor IX mutation

  1993cited by this paper
• In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs.

  1993cited by this paper
• PACE/furin can process the vitamin K-dependent pro-factor IX precursor within the secretory pathway.

  1993cited by this paper
• Regulation of the phosphoenolpyruvate carboxykinase/human factor IX gene introduced into the livers of adult rats by receptor‐mediated gene transfer

  1993cited by this paper
• Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII.

  1993cited by this paper
• Carbohydrate residues modulate the activation of coagulation factor X.

  1993cited by this paper
• In vitro and in vivo functional characterization of bovine vitamin K-dependent gamma-carboxylase expressed in Chinese hamster ovary cells.

  1993cited by this paper
• Antibody-probed conformational transitions in the protease domain of human factor IX upon calcium binding and zymogen activation: putative high-affinity Ca(2+)-binding site in the protease domain.

  1992cited by this paper
• Mutation creates an open reading frame within the 5' untranslated region of macaque erythrocyte carbonic anhydrase (CA) I mRNA that suppresses CA I expression and supports the scanning model for translation.

  1992cited by this paper
• Assessing the underlying pattern of human germline mutations: lessons from the factor IX gene

  1992cited by this paper
• Haemophilia B: database of point mutations and short additions and deletions--third edition, 1992.

  1992cited by this paper
• Construction, expression, and characterization of a chimera of factor IX and factor X. The role of the second epidermal growth factor domain and serine protease domain in factor Va binding.

  1992cited by this paper
• Recovery from hemophilia B Leyden: an androgen-responsive element in the factor IX promoter.

  1992cited by this paper
• Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes.

  1992cited by this paper
• The binding of human factor IX to endothelial cells is mediated by residues 3-11.

  1992cited by this paper
• Human gene therapy.

  1992cited by this paper
• Expression of human factor IX in mice after injection of genetically modified myoblasts.

  1992cited by this paper
• Human gene therapy comes of age

  1992cited by this paper
• A microsomal endopeptidase from liver with substrate specificity for processing proproteins such as the vitamin K-dependent proteins of plasma.

  1992cited by this paper
• Disruption of a binding site for hepatocyte nuclear factor 4 results in hemophilia B Leyden.

  1992cited by this paper
• Expression of human factor IX in rat capillary endothelial cells: toward somatic gene therapy for hemophilia B.

  1991cited by this paper
• Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation.

  1991cited by this paper
• Haemophilia B Leyden arising de novo by point mutation in the putative factor IX promoter region

  1991cited by this paper
• Factor XI activation in a revised model of blood coagulation

  1991cited by this paper
• Structure-function relationships of epidermal growth factor modules in vitamin K-dependent clotting factors.

  1991cited by this paper
• Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants.

  1991cited by this paper
• Structural features in eukaryotic mRNAs that modulate the initiation of translation.

  1991cited by this paper
• Structural requirements for Ca2+ binding to the gamma-carboxyglutamic acid and epidermal growth factor-like regions of factor IX. Studies using intact domains isolated from controlled proteolytic digests of bovine factor IX.

  1991cited by this paper
• Characterization of a Mouse Factor IX cDNA and Developmental Regulation of the Factor IX Gene Expression in Liver

  1991cited by this paper
• Somatic mosaicism and female-to-female transmission in a kindred with hemophilia B (factor IX deficiency).

  1991cited by this paper
• Molecular characterization of severe hemophilia A suggests that about half the mutations are not within the coding regions and splice junctions of the factor VIII gene.

  1991cited by this paper
• Segments containing alternating purine and pyrimidine dinucleotides: patterns of polymorphism in humans and prevalence throughout phylogeny.

  1991cited by this paper
• Cloning and expression of the cDNA for human gamma-glutamyl carboxylase.

  1991cited by this paper
• The coagulation cascade: initiation, maintenance, and regulation.

  1991cited by this paper
• Missense mutations and evolutionary conservation of amino acids: evidence that many of the amino acids in factor IX function as "spacer" elements.

  1991cited by this paper
• Why does the human factor IX gene have a G + C content of 40%?

  1991cited by this paper
• T296→M, a common mutation causing mild hemophilia B in the Amish and others: founder effect, variability in factor IX activity assays, and rapid carrier detection

  1991cited by this paper
• Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces.

  1991cited by this paper
• The Extrinsic Pathway Inhibitor: A Regulator of Tissue Factor-Dependent Blood Coagulation

  1991cited by this paper
• HNF-1, a member of a novel class of dimerizing homeodomain proteins.

  1991cited by this paper
• The Structures of Domains of Blood Proteins

  1991cited by this paper
• von Willebrand factor.

  1991cited by this paper
• Localization of transcription initiation sites in the human coagulation factor IX gene

  1990cited by this paper
• Blood coagulation factors in human embryonic-fetal development: preferential expression of the FVII/tissue factor pathway.

  1990cited by this paper
• Comparative sequence analysis of mammalian factor IX promoters.

  1990cited by this paper
• Expression of a human proprotein processing enzyme: correct cleavage of the von Willebrand factor precursor at a paired basic amino acid site.

  1990cited by this paper
• Experimental and theoretical evidence supporting the role of Gly363 in blood coagulation factor IXa (Gly193 in chymotrypsin) for proper activation of the proenzyme.

  1990cited by this paper
• Factor IXHollywood: substitution of Pro55 by Ala in the first epidermal growth factor-like domain.

  1990cited by this paper
• Increased biological activity of a recombinant factor IX variant carrying alanine at position +1.

  1990cited by this paper
• Vitamin K-dependent carboxylase: structural requirements for propeptide activation.

  1990cited by this paper
• Factor IX Chongqing: a New Mutation in the Calcium-Binding Domain of Factor IX Resulting in Severe Hemophilia B

  1990cited by this paper
• Factor IX is activated in vivo by the tissue factor mechanism.

  1990cited by this paper
• Regulation of ferritin and transferrin receptor mRNAs.

  1990cited by this paper
• The first EGF‐like domain from human factor IX contains a high‐affinity calcium binding site.

  1990cited by this paper
• Regulation of coagulation by a multivalent Kunitz-type inhibitor.

  1990cited by this paper
• Expression and characterization of human factor IX and factor IX-factor X chimeras in mouse C127 cells.

  1990cited by this paper
• Factor IX New London: substitution of proline for glutamine at position 50 causes severe hemophilia B.

  1990cited by this paper
• Recombination between two 14-bp homologous sequences as the mechanism for gene deletion in factor IX Seattle 1.

  1990cited by this paper
• Novel short interspersed repeat in human DNA

  1990cited by this paper
• Organization of the human protein S genes.

  1990cited by this paper
• The structure of (xylose)2glucose-O-serine 53 found in the first epidermal growth factor-like domain of bovine blood clotting factor IX.

  1990cited by this paper
• Expression of human factor IX in rabbit hepatocytes by retrovirus-mediated gene transfer: potential for gene therapy of hemophilia B.

  1990cited by this paper
• Functional characterization of the 5'-regulatory region of human factor IX gene.

  1990cited by this paper
• 1H NMR assignment and secondary structure of the Ca2(+)-free form of the amino-terminal epidermal growth factor like domain in coagulation factor X.

  1990cited by this paper
• Characterization of recombinant human factor IX expressed in transgenic mice and in derived trans‐immortalized hepatic cell lines.

  1990cited by this paper
• An HhaI polymorphism is present in factor IX genes of Asian subjects

  1990cited by this paper
• Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia B

  1990cited by this paper
• Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs.

  1990cited by this paper
• Structural and functional basis of the developmental regulation of human coagulation factor IX gene: factor IX Leyden.

  1990cited by this paper
• Production of human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia B.

  1989cited by this paper
• Inhibitors of 2-ketoglutarate-dependent dioxygenases block aspartyl beta-hydroxylation of recombinant human factor IX in several mammalian expression systems.

  1989cited by this paper
• Tat trans-activates the human immunodeficiency virus through a nascent RNA target.

  1989cited by this paper
• A negative regulatory element with properties similar to those of enhancers is contained within an Alu sequence

  1989cited by this paper
• Functionally important regions of the factor IX gene have a low rate of polymorphism and a high rate of mutation in the dinucleotide CpG.

  1989cited by this paper
• Detection of polymorphisms at cytosine phosphoguanadine dinucleotides and diagnosis of haemophilia B carriers.

  1989cited by this paper
• Access to a messenger RNA sequence or its protein product is not limited by tissue or species specificity.

  1989cited by this paper
• HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation.

  1989cited by this paper
• Calcium binding and putative activity of the epidermal growth factor domain of blood coagulation factor IX.

  1989cited by this paper
• Molecular cloning of a cDNA encoding canine factor IX.

  1989cited by this paper
• Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins.

  1989cited by this paper
• Characterisation of two differently processed forms of human recombinant factor IX synthesised in CHO cells transformed with a polycistronic vector.

  1988cited by this paper
• Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man

  1988cited by this paper
• Development of the human coagulation system in the healthy premature infant.

  1988cited by this paper
• A second BamHI DNA polymorphism and haplotype association in the factor IX gene.

  1988cited by this paper
• An alternative approach to somatic cell gene therapy.

  1988cited by this paper
• An insertion within the factor IX gene: hemophilia BEl Salvador.

  1988cited by this paper
• The putative factor IX gene promoter in hemophilia B Leyden.

  1988cited by this paper
• Purified hepatocyte nuclear factor 1 interacts with a family of hepatocyte-specific promoters.

  1988cited by this paper
• Mild hemophilia A associated with a cryptic donor splice site mutation in intron 4 of the factor VIII gene.

  1988cited by this paper
• The propeptide of von Willebrand factor independently mediates the assembly of von Willebrand multimers.

  1988cited by this paper
• Efficient isolation of X chromosome-specific single-copy probes from a cosmid library of a human X/hamster hybrid-cell line: mapping of new probes close to the locus for X-linked mental retardation.

  1987cited by this paper
• Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation.

  1987cited by this paper
• Expression of variant von Willebrand factor (vWF) cDNA in heterologous cells: requirement of the pro‐polypeptide in vWF multimer formation.

  1987cited by this paper
• Nucleotide sequence of the gene for human prothrombin.

  1987cited by this paper
• A DNA marker closely linked to the factor IX (haemophilia B) gene

  1987cited by this paper
• Development of the human coagulation system in the full-term infant.

  1987cited by this paper

• Blood Coagulation Factor IX: Structure, Function, and Regulation

  2025cites this paper
• Plasma factor IX: The tip of the iceberg?

  2021cites this paper
• Expression of a human cDNA in moss results in spliced mRNAs and fragmentary protein isoforms

  2020cites this paper
• Strategies for Blood Product Management, Reducing Transfusions, and Massive Blood Transfusion

  2019cites this paper
• Laboratory monitoring issues in recombinant porcine FVIII replacement in acquired haemophilia A

  2018cites this paper
• A novel missense mutation, p.Phe360Cys, in FIX gene results in haemophilia B in a female patient with skewed X‐inactivation

  2018cites this paper
• Characterization of IXINITY® (Trenonacog Alfa), a Recombinant Factor IX with Primary Sequence Corresponding to the Threonine-148 Polymorph

  2016cites this paper
• Engineering protein processing of the mammary gland to produce abundant hemophilia B therapy in milk

  2015cites this paper
• The role of Rixubis™ in the treatment of hemophilia B.

  2014cites this paper
• PRODUCTION OF RECOMBINANT HUMAN COAGULATION FACTOR IX BY TRANSGENIC PIG

  2014cites this paper
• Anion-exchange purification of recombinant factor IX from cell culture supernatant using different chromatography supports.

  2013cites this paper
• Hemophilia clinical gene therapy: brief review.

  2013cites this paper
• Treatment of hemophilia B: focus on recombinant factor IX

  2013cites this paper
• Haemophilia B: current pharmacotherapy and future directions

  2012cites this paper
• Recent advances in the development of coagulation factors and procoagulants for the treatment of hemophilia.

  2011cites this paper
• CHAPTER 10 – Strategies for Blood Product Management and Reducing Transfusions

  2009cites this paper
• Purification of recombinant DNA-derived factor IX produced in transgenic pig milk and fractionation of active and inactive subpopulations.

  2004cites this paper
• Germline mosaicism resulting in the transmission of severe hemophilia B from a grandfather with a mild deficiency

  2004cites this paper
• Advances in care of children with hemophilia.

  2003cites this paper
• Advances in Care of Children with Hemophilia

  2003cites this paper
• Gene therapy for hemophilia

  2001cites this paper
• Inherited Bleeding Disorders in Dermatologic Surgery

  2001cites this paper
• Genetic mechanisms of age regulation of blood coagulation: factor IX model.

  2000cites this paper
• Somatic mosaicism and compound heterozygosity in female hemophilia B.

  2000cites this paper
• Genetic and Molecular Mechanisms of Age Regulation (Homeostasis) of Blood Coagulation

  2000cites this paper
• Induction of immune tolerance and suppression of anaphylaxis in a child with haemophilia B by simple plasmapheresis and antigen exposure

  2000cites this paper
• Kinetics of Recombinant Adeno-Associated Virus-Mediated Gene Transfer

  2000cites this paper
• Genetic mechanisms of age regulation of human blood coagulation factor IX.

  1999cites this paper
• Transgenic pigs as bioreactors: a comparison of gamma-carboxylation of glutamic acid in recombinant human protein C and factor IX by the mammary gland.

  1999cites this paper
• Targeted inactivation of the coagulation factor IX gene causes hemophilia B in mice.

  1998cites this paper
• Gene therapy for hemophilia: hopes and hurdles

  1998cites this paper
• Ex Vivo Fibroblast Transduction in Rabbits Results in Long-Term (>600 Days) Factor IX Expression in a Small Percentage of Animals

  1998cites this paper
• Structural determination of lipid-bound human blood coagulation factor IX.

  1998cites this paper
• Covalent Fixation of Soluble Derivatized Dextrans to Model Proteins in Low-Concentration Medium: Application to Factor IX and Protein C

  1998cites this paper
• Comparison of Retroviral and Adeno-Associated Viral Vectors Designed to Express Human Clotting Factor IX

  1997cites this paper
• A coagulation factor IX-deficient mouse model for human hemophilia B.

  1997cites this paper
• The carboxyl-terminal region of factor IX is essential for its secretion.

  1997cites this paper
• Gene therapy for haemophilia.

  1997cites this paper
• Persistent systemic production of human factor IX in mice by skeletal myoblast-mediated gene transfer: feasibility of repeat application to obtain therapeutic levels.

  1997cites this paper
• Isolation and Characterization of Canine Factor IX

  1996cites this paper
• The factor IX gene as a model for analysis of human germline mutations: an update.

  1996cites this paper
• X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B.

  1995cites this paper
• Role of Intron I in Expression of the Human Factor IX Gene (*)

  1995cites this paper
• Orthotopic liver transplantation in hemophilia B: a case report

  1995cites this paper
• Regulatory Mechanism of the Factor IX Gene

  1995influential citation
• Prospects for gene therapy of haemophilia A and B.

  1995cites this paper
• Mögliche Techniken für eine Hämophilie-Gentherapie

  1994cites this paper